NASDAQ:OMER

Omeros Stock Predictions

Healthcare > Biotechnology

Buy OMER

*Your capital is at risk

$10.72

+0.140 (+1.32%)

At Close: Jun 25, 2026

Currently predicting for Fri, 26 Jun 2026

OMER Live board

Community Bull/Bear

Target Next close

Join the OMER prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

OMER Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For OMER

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

OMER Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT OMEROS CORPORATION

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell tr...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
JLL $298.94	1.61%	Jun 23
CBRE $133.21	1.03%	Jun 23
CAG $13.43	2.72%	Jun 23
TTEK $28.04	1.43%	Jun 23
NESR $25.07	7.62%	Jun 23

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by